Johnson & Johnson Asia-Pacific, Africa — Sales to customers (Note 9) increased by 2.6% to $3.59B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.5%, from $3.31B to $3.59B. Over 4 years (FY 2021 to FY 2025), Asia-Pacific, Africa — Sales to customers (Note 9) shows relatively stable performance with a 0.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates successful market expansion or higher demand for products in these regions, while a decrease may signal competitive pressure or regional economic headwinds.
This metric represents the total revenue generated from external customers located within the Asia-Pacific and Africa ge...
Comparable to regional revenue reporting by other multinational pharmaceutical or consumer health companies, often categorized by geographic segment.
jnj_segment_asia_pacific_africa_sales_to_customers_note_9| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.36B | $4.29B | $560.00M | $4.51B | $4.20B | $3.30B | $2.97B | $3.45B | $3.60B | $3.46B | $3.26B | $3.41B | $3.45B | $3.48B | $3.26B | $3.31B | $3.61B | $3.61B | $3.50B | $3.59B |
| QoQ Change | — | -1.6% | -86.9% | +704.6% | -6.7% | -21.5% | -9.9% | +16.0% | +4.3% | -3.8% | -5.8% | +4.5% | +1.4% | +0.7% | -6.2% | +1.6% | +8.9% | +0.2% | -3.2% | +2.6% |
| YoY Change | — | — | — | — | -3.6% | -23.1% | +430.5% | -23.5% | -14.4% | +4.8% | +9.7% | -1.2% | -4.0% | +0.5% | +0.1% | -2.8% | +4.5% | +4.0% | +7.4% | +8.5% |